DPP4 and diabetes mellitus: Notably, DPP4 inhibitors have been reported to induce conformational changes in DPP4, suggesting that their effects extend beyond merely neutralising sDPP4.31‐33 Current studies have shown an increased risk of diabetes in patients with IBD,34but clinical data on concurrent use of DPP4 inhibitors in CD remain limited.